In addition, empagliflozin reduced CaMKII activity, and the CaMKII-dependent SR Ca2+ leak and improved Ca2+ transients may contribute to antiarrhythmic and contractile functions which enhance the empagliflozin effect in HF [152]. The gene discussed is CAMK2G; the disease is hydrops fetalis.